Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1maturation inhibitor bevirimat

Documenti analoghi

• Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1
  di: Van Baelen, Kurt, et al.
  Pubblicazione: (2009)
• HIV-1 Maturation Inhibitor Bevirimat Stabilizes the Immature Gag Lattice
  di: Keller, Paul W., et al.
  Pubblicazione: (2011)
• A Single Polymorphism in HIV-1 Subtype C SP1 Is Sufficient To Confer Natural Resistance to the Maturation Inhibitor Bevirimat
  di: Lu, Wuxun, et al.
  Pubblicazione: (2011)
• The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles
  di: Nguyen, Albert T, et al.
  Pubblicazione: (2011)
• In Vitro Resistance to the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PA-457 (Bevirimat)
  di: Adamson, Catherine S., et al.
  Pubblicazione: (2006)